These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

714 related items for PubMed ID: 16126322

  • 1. Digital rectal examination is no longer necessary in the routine follow-up of men with undetectable prostate specific antigen after radical prostatectomy: the implications for follow-up.
    Chaplin BJ, Wildhagen MF, Schroder FH, Kirkels WJ, Bangma CH.
    Eur Urol; 2005 Dec; 48(6):906-10. PubMed ID: 16126322
    [Abstract] [Full Text] [Related]

  • 2. Digital rectal examination and imaging studies are unnecessary in men with undetectable prostate specific antigen following radical prostatectomy.
    Pound CR, Christens-Barry OW, Gurganus RT, Partin AW, Walsh PC.
    J Urol; 1999 Oct; 162(4):1337-40. PubMed ID: 10492192
    [Abstract] [Full Text] [Related]

  • 3. Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy.
    Do T, Parker RG, Do C, Tran L, Do L, Dolkar D.
    Cancer J Sci Am; 1998 Oct; 4(5):324-30. PubMed ID: 9815297
    [Abstract] [Full Text] [Related]

  • 4. The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy.
    Ward JF, Blute ML, Slezak J, Bergstralh EJ, Zincke H.
    J Urol; 2003 Nov; 170(5):1872-6. PubMed ID: 14532796
    [Abstract] [Full Text] [Related]

  • 5. Preoperative PSA level significantly associated with interval to biochemical progression after radical retropubic prostatectomy.
    Gonzalez CM, Roehl KA, Antenor JV, Blunt LW, Han M, Catalona WJ.
    Urology; 2004 Oct; 64(4):723-8. PubMed ID: 15491709
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Accuracy of predicting long-term prostate specific antigen outcome based on early prostate specific antigen recurrence results after radical prostatectomy.
    Soergel TM, Koch MO, Foster RS, Bihrle R, Wahle G, Gardner T, Jung SH.
    J Urol; 2001 Dec; 166(6):2198-201. PubMed ID: 11696735
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
    Ward JF, Slezak JM, Blute ML, Bergstralh EJ, Zincke H.
    BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.
    Paparel P, Cronin AM, Savage C, Scardino PT, Eastham JA.
    Eur Urol; 2009 Feb; 55(2):404-10. PubMed ID: 18639970
    [Abstract] [Full Text] [Related]

  • 20. Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels.
    Rogers E, Ohori M, Kassabian VS, Wheeler TM, Scardino PT.
    J Urol; 1995 Jan; 153(1):104-10. PubMed ID: 7526002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.